Proto Labs, Inc.
NYSE:PRLBManufacturing - Miscellaneous
+$1.44 today
- Market cap
- $1.53B
- Beta
- 1.39
- P/E (TTM)
- 75.0
- EPS (TTM)
- $1.08
Volume 0.23M
Average 0.18M
PRLB Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Proto Labs, Inc.NYSE: PRLB
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development dips below year-ago levels
Q2 FY2026 research & development of $10.79M fell 3.4% year over year, behind the +2.7% change in trailing-twelve-month research & development. Sequentially, it rose 2.4% from the prior quarter. Over 3 fiscal years it compounded at +3.8% a year.
Context
- Research & development amounted to 8.0% of revenue in FY2025, down 0.2 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -3.4% toward the trailing-twelve-month pace of +2.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 42.81M USD
- Year-over-year change
- +3.7%
- 4-year CAGR
- -0.8%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.81M | +3.7% |
| FY2024 | 2024-12-31 | 41.3M | +2.9% |
| FY2023 | 2023-12-31 | 40.14M | +5.0% |
| FY2022 | 2022-12-31 | 38.22M | -13.6% |
| FY2021 | 2021-12-31 | 44.24M | — |
Research & Development vs competitors
How PRLB compares with its peers on the latest reported figures
- PRLB's LTM Jun 2026 research & development of $42.36M is the 2nd highest of the 10 companies compared; the peer median is $0.
- Its year-over-year change of +2.7% is the 3rd highest of 4, against a peer median of +10.1%.
- Research & development amounts to 7.6% of revenue for PRLB, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
EVEXEve Holding, Inc. | LTM Mar 2026 | $209.06M | +42.1% | +55.4% | — |
| LTM Jun 2026 | $42.36M | +2.7% | +3.8% | 7.6% | |
| LTM Feb 2026 | $18.62M | +10.1% | +5.8% | 2.9% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| LTM Feb 2026 | $0 | -100.0% | +0.6% | 0.0% | |
CCECCapital Clean Energy Carriers Corp. | FY2025 | $0 | — | — | 0.0% |
RHLDResolute Holdings Management, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PRLB) | $0 | +10.1% | +5.8% | 0.0% | |
Competitors are the stored peer set for PRLB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 488.1M | 488.4M | 503.88M | 500.89M | 533.13M |
| Cost of Revenue | 265.41M | 272.93M | 281.88M | 277.69M | 295.99M |
| Gross Profit | 222.69M | 215.47M | 221.99M | 223.2M | 237.14M |
| Gross Margin | 45.6% | 44.1% | 44.1% | 44.6% | 44.5% |
| Research & Development | 44.24M | 38.22M | 40.14M | 41.3M | 42.81M |
| Selling, General & Admin | 150.61M | 150.3M | 153.48M | 156.41M | 168.13M |
| Operating Expenses | 194.85M | 188.52M | 193.61M | 197.7M | 210.94M |
| Depreciation & Amortization | 40.49M | 39.43M | 37.53M | 35.81M | 33.81M |
| EBITDA | 80.67M | (58.45M) | 66.58M | 60.68M | 64.88M |
| EBITDA Margin | 16.5% | -12.0% | 13.2% | 12.1% | 12.2% |
| Operating Income | 27.84M | 26.95M | 28.38M | 25.5M | 26.2M |
| Operating Margin | 5.7% | 5.5% | 5.6% | 5.1% | 4.9% |
| Interest Income | 200K | 1M | 3.3M | 5.4M | 0 |
| Interest Expense | 0 | 0 | 1.1M | 200K | 0 |
| Other Income / Expenses | 12.35M | (124.82M) | (430K) | (824K) | 4.86M |
| Income Before Tax | 40.18M | (97.88M) | 27.95M | 24.67M | 31.06M |
| Pre-Tax Margin | 8.2% | -20.0% | 5.5% | 4.9% | 5.8% |
| Income Tax Expense | 6.81M | 5.59M | 10.73M | 8.08M | 9.82M |
| Net Income | 33.37M | (103.46M) | 17.22M | 16.59M | 21.24M |
| Net Margin | 6.8% | -21.2% | 3.4% | 3.3% | 4.0% |
| EPS (Basic) | 1.21 | (3.77) | 0.66 | 0.66 | 0.89 |
| EPS (Diluted) | 1.21 | (3.77) | 0.66 | 0.66 | 0.88 |
| Weighted Avg Shares | 27.62M | 27.41M | 26.19M | 25.1M | 23.92M |
| Weighted Avg Shares (Diluted) | 27.65M | 27.41M | 26.22M | 25.21M | 24.25M |
Proto Labs, Inc.
NYSE:PRLB
Intrinsic Alpha fair value
Locked
Current Price
$63.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.